172 related articles for article (PubMed ID: 19800397)
1. Novel approach to demonstrate high efficacy of mu opioids in the rat vas deferens: a simple model of predictive value.
Riba P; Friedmann T; Király KP; Al-Khrasani M; Sobor M; Asim MF; Spetea M; Schmidhammer H; Furst S
Brain Res Bull; 2010 Jan; 81(1):178-84. PubMed ID: 19800397
[TBL] [Abstract][Full Text] [Related]
2. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
[TBL] [Abstract][Full Text] [Related]
3. Some pharmacological properties of a newly synthesized 3-acetoxy-6 beta-acetylthio-10-oxo-N-cyclopropylmethyl-dihydronormorphine (KT-95).
Hosoki R; Niizawa S; Koike K; Sagara T; Kanematsu K; Takayanagi I
Arch Int Pharmacodyn Ther; 1996; 331(2):136-52. PubMed ID: 8937625
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, opioid receptor binding, and biological activities of naltrexone-derived pyrido- and pyrimidomorphinans.
Ananthan S; Kezar HS; Carter RL; Saini SK; Rice KC; Wells JL; Davis P; Xu H; Dersch CM; Bilsky EJ; Porreca F; Rothman RB
J Med Chem; 1999 Sep; 42(18):3527-38. PubMed ID: 10479286
[TBL] [Abstract][Full Text] [Related]
5. Chronic exposure to mu-opioid agonists produces constitutive activation of mu-opioid receptors in direct proportion to the efficacy of the agonist used for pretreatment.
Liu JG; Prather PL
Mol Pharmacol; 2001 Jul; 60(1):53-62. PubMed ID: 11408600
[TBL] [Abstract][Full Text] [Related]
6. Receptor constants for endomorphin-1 and endomorphin-1-ol indicate differences in efficacy and receptor occupancy.
Al-Khrasani M; Orosz G; Kocsis L; Farkas V; Magyar A; Lengyel I; Benyhe S; Borsodi A; Rónai AZ
Eur J Pharmacol; 2001 Jun; 421(1):61-7. PubMed ID: 11408050
[TBL] [Abstract][Full Text] [Related]
7. Signal transduction efficacy of the highly potent mu opioid agonist 14-methoxymetopon.
Zernig G; Saria A; Krassnig R; Schmidhammer H
Life Sci; 2000 Mar; 66(19):1871-7. PubMed ID: 10809184
[TBL] [Abstract][Full Text] [Related]
8. Opioid agonist affinity in the guinea-pig ileum and mouse vas deferens.
Porreca F; LoPresti D; Ward SJ
Eur J Pharmacol; 1990 Apr; 179(1-2):129-39. PubMed ID: 2163849
[TBL] [Abstract][Full Text] [Related]
9. HS-599: a novel long acting opioid analgesic does not induce place-preference in rats.
Lattanzi R; Negri L; Giannini E; Schmidhammer H; Schutz J; Improta G
Br J Pharmacol; 2001 Sep; 134(2):441-7. PubMed ID: 11564664
[TBL] [Abstract][Full Text] [Related]
10. Methocinnamox is a potent, long-lasting, and selective antagonist of morphine-mediated antinociception in the mouse: comparison with clocinnamox, beta-funaltrexamine, and beta-chlornaltrexamine.
Broadbear JH; Sumpter TL; Burke TF; Husbands SM; Lewis JW; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2000 Sep; 294(3):933-40. PubMed ID: 10945843
[TBL] [Abstract][Full Text] [Related]
11. Delta receptors in the rat vas deferens.
Smith CF; Carter A
Arch Int Pharmacodyn Ther; 1986 Dec; 284(2):181-92. PubMed ID: 3030209
[TBL] [Abstract][Full Text] [Related]
12. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
[TBL] [Abstract][Full Text] [Related]
13. Highly potent novel opioid receptor agonist in the 14-alkoxymetopon series.
Fürst Z; Búzás B; Friedmann T; Schmidhammer H; Borsodi A
Eur J Pharmacol; 1993 May; 236(2):209-15. PubMed ID: 8391457
[TBL] [Abstract][Full Text] [Related]
14. Morphine-6 beta-glucuronide has a higher efficacy than morphine as a mu-opioid receptor agonist in the rat locus coeruleus.
Osborne PB; Chieng B; Christie MJ
Br J Pharmacol; 2000 Dec; 131(7):1422-8. PubMed ID: 11090116
[TBL] [Abstract][Full Text] [Related]
15. Stimulation of guanosine-5'-o-(3-[35S]thio)triphosphate binding in digitonin-permeabilized C6 rat glioma cells: evidence for an organized association of mu-opioid receptors and G protein.
Alt A; McFadyen IJ; Fan CD; Woods JH; Traynor JR
J Pharmacol Exp Ther; 2001 Jul; 298(1):116-21. PubMed ID: 11408532
[TBL] [Abstract][Full Text] [Related]
16. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells.
Gray RE; Munks MW; Haynes RR; Olsen GD
Brain Res Bull; 2001 Mar; 54(5):499-505. PubMed ID: 11397539
[TBL] [Abstract][Full Text] [Related]
17. Affinity profiles of novel delta-receptor selective benzofuran derivatives of non-peptide opioids.
Spetea M; Nevin ST; Hosztafi S; Rónai AZ; Tóth G; Borsodi A
Neurochem Res; 1998 Sep; 23(9):1211-6. PubMed ID: 9712193
[TBL] [Abstract][Full Text] [Related]
18. Opiate receptors in the rat vas deferens.
Smith CF; Rance MJ
Life Sci; 1983; 33 Suppl 1():327-30. PubMed ID: 6319887
[TBL] [Abstract][Full Text] [Related]
19. An attempt to structurally convert mu-selective morphine toward delta-receptor binding: dimerization based on enkephalin conformation.
Yara H; Katagawa Y; Doi M; Ishida T; Inoue M; Yasuda M; Baba A; Iwata H; Kitamura K; Sadatome T
Eur J Pharmacol; 1990 Jun; 188(6):359-68. PubMed ID: 2164938
[TBL] [Abstract][Full Text] [Related]
20. Clocinnamox dose-dependently antagonizes morphine-analgesia and [3H]DAMGO binding in rats.
Paronis CA; Woods JH
Eur J Pharmacol; 1997 Oct; 337(1):27-34. PubMed ID: 9389377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
